For Shame: ‘Pharma Bro’ Shkreli Is In Prison, But Daraprim’s Price Is Still High

Washington Post, May 4, 2018
Shefali Luthra, quoting W. Nicholson Price II (Academic Fellow Alumnus)

From the article: The continued high price of the drug is a cautionary tale to those who hope that public shaming of a few “bad actors” can curb escalating drug prices, because the problem is rooted in the market’s underlying financial incentives. …

Read More

Trump is set to unveil his plan to lower drug prices. Here are four things to watch for.

The Washington Post, May 10, 2018
Carolyn Y. Johnson, quoting Rachel Sachs (Academic Fellow Alumna)

From the article: President Trump will deliver Friday afternoon a twice-delayed, much-anticipated speech about his plan to lower drug prices — after a year when harsh rhetoric against drugmakers was accompanied by little action.

Read More

Work Requirements Give Republicans Cover to Expand Medicaid

U.S. News, April 23, 2018
Gabrielle Levy, quoting Allison K. Hoffman (Academic Fellow Alumna)

From the article: While the Medicaid law sets certain mandatory minimums of eligibility and coverage, the waiver program allows states wide latitude to run their programs as they see fit. For state Republican lawmakers demonstrating a willingness to consider Medicaid…

Read More

HealthAffairs Podcast: Precision Medicine

Health Affairs Podcast, May 8, 2018
Jonathan J. Darrow (Student Fellow Alumnus), Alan Weil, Geoffrey Ginsburg, Alessandro Blasimme, Kathryn A. Phillips, Daryl Pritchard,

Overview of the Podcast: The May 2018 issue of Health Affairs on "Precision Medicine," contains a timely and comprehensive look at the use of data and genetic information to better diagnose and treat patients. It features real world examples of how precision medicine…

Read More

Authorities Use DNA Testing Service to Identify “Golden State Killer” - What Does This Mean for You?

WCIA, The Takeaway, May 7, 2018
Heather Goldstone & Elsa Partan, quoting I. Glenn Cohen (Faculty Director)

From the article: Late last month, authorities charged a man in Sacramento County, California as the so-called Golden State Killer after tracking him down with a private DNA test company, one called GEDmatch.  Joseph James DeAngelo is accused of…

Read More

Planned Parenthood sues Trump administration over federal funding

The Washington Times, May 2, 2018
Alex Swoyer, quoting I. Glenn Cohen (Faculty Director)

From the article: Three Planned Parenthood affiliates sued Wednesday to demand taxpayer money keep flowing to the country’s largest abortion network, saying a new Trump administration policy appears designed to cut them out of family planning money. …

Read More

For Shame: ‘Pharma Bro’ Shkreli Is In Prison, But Daraprim’s Price Is Still High

The Washington Post , May 4, 2018
Shefali Luthra, quoting W. Nicholson Price (Academic Fellow Alumnus)

From the article: It was 2015 when Martin Shkreli, then CEO of Turing Pharmaceuticals and the notorious “pharma bro,” jacked up the cost of the lifesaving drug Daraprim by 5,000 percent. Overnight, its price tag skyrocketed from $13.50…

Read More

What your government can’t tell you about drug prices

CBC News, May 3, 2018
Kelly Crowe, Suit brought by Jean-Christophe Belisle Pipon (Visiting Researcher)

From the article: It took three years of fighting for access to confidential drug information, but a Quebec bioethicist has punched a tiny hole in the iron wall of secrecy surrounding patented drug prices. Two weeks ago, Jean-Christophe Bé​lisle…

Read More

S.J.D. candidate awarded scholarship to study health activism from a legal perspective

Harvard Law Today, May 1, 2018
Audrey Kunycky, reporting on Maayan Sudai (Student Fellow Alumna)

From the article: Maayan Sudai, an S.J.D. candidate at Harvard Law School, has been awarded a prestigious scholarship from Israel’s Dan David Foundation to support her work examining health activism from a legal perspective. Every…

Read More

Vaccine against Meningitis: Quebec Pays Twice As Much As United Kingdom

La Presse, April 25, 2018
Marie-Claude Malboeuf, Suit brought by Jean-Christophe Belisle Pipon (Visiting Researcher)

From the article: Quebec has agreed to pay twice as much as the United Kingdom for a new vaccine against meningitis, the effectiveness of which seemed uncertain. The disclosure of the price paid by Quebec - about $80 a dose - was…

Read More

Supreme Court rules that patent reviews detested by pharma are constitutional

STAT, April 24, 2018
Ed Silverman, quoting Rachel Sachs (Academic Fellow Alumna)

From the article: In a blow to the pharmaceutical industry, the U.S. Supreme Court ruled that a controversial procedure for reviewing patent disputes does not violate the constitutional rights of patent holders. Known as inter partes…

Read More

Federal Appeals Court Finds State’s Drug Price-Gouging Law Unconstitutional

Shots: Health News From NPR, April 17, 2018
Shefali Luthra, quoting Rachel Sachs (Academic Fellow Alumna)

From the article: States are continuing to do battle with budget-busting prices of prescription drugs. But a recent federal court decision could limit the tools available to them — underscoring the challenge states face as, in the absence of federal action,…

Read More

The breakthrough therapy designation for promising cancer drugs is good for patients

STAT, April 27, 2018
Jeff Allen, quoting Jonathan J. Darrow (Student Fellow Alumnus)

From the article: One exciting component of the Food and Drug Administration Safety and Innovation Act was the creation of the breakthrough therapy designation. It allows an all-hands-on-deck approach at the FDA to determine the best path forward when the…

Read More

Assessing the FDA’s Breakthrough Drug Program After Six Years

ASH Clinical News, April 25, 2018
ASH Clinical News, quoting Jonathan J. Darrow (Student Fellow Alumnus)

From the article: In the first four years of the U.S. Food and Drug Administration’s (FDA) breakthrough-therapy designation program, the agency approved 31 “breakthrough” drugs, but many were approved with limited evidence of added benefit, according…

Read More

REPORT: Ethical Issues Related to the Creation of Synthetic Human Embryos

Harvard University Embryonic Stem Cell Research Oversight (“ESCRO”) Committee, April 2018

Report Summary Authored by Robert D. Truog, MD (Center for Bioethics, Harvard Medical School) and Melissa J. Lopes, JD…

Read More

THE PRICE OF VACCINES MUST BE DISCLOSED, ORDERS A COURT

La Presse, April 19, 2018
Marie-Claude Malboeuf, Suit brought by Jean-Christophe Belisle Pipon (Visiting Researcher)

From the article: Pharmaceutical companies doing business with the government will no longer be able to hide how much money they are getting to provide vaccines. This is what the Commission for Access to Information (CAI) has just…

Read More

Move over right-to-try: FDA looks at improving clinical trial enrollment

Politico, April 16, 2018
Sarah Karlin-Smith, quoting Jonathan J. Darrow (Student Fellow Alumnus)

From the article: The FDA’s bar for “breakthrough” designation may be too low, Harvard Medical School policy researchers argue in the New England Journal of Medicine. The designation was created by Congress in 2012 for new drugs that preliminary…

Read More

Parenting of the future: Many embryos, each with DNA profile

The Washington Post , April 18, 2018
Malcolm Ritter, quoting I. Glenn Cohen (Faculty Director)

From the article: Once the genetic profile is done, could it come back to haunt a child if, say, a life insurer or nursing home demanded to see it to assess disease risk? How would the large number of rejected embryos be handled ethically and politically?

Read More

New Article Examines the Possibility of Applying Workplace Safety Rules to the NFL

Part of the Law and Ethics Initiative of the Football Players Health Study at Harvard University, April 17, 2018
Article authored by Adam M. Finkel, Chris Deubert, Orly Lobel, I. Glenn Cohen (Faculty Director), and Holly Fernandez Lynch (Former Executive Director

Could occupational health and safety laws be applied to better protect NFL players? A new analysis, published on April 17 in the Arizona Law Review, explores this very possibility. …

Read More

Is the ‘Breakthrough Therapy’ Process Putting Dangerous Drugs on Store Shelves?

Healthline, April 17, 2018
Shawn Radcliffe, quoting Jonathan J. Darrow (Student Fellow Alumnus)

From the article: A CNN report last week detailed the deaths of more than 700 patients prescribed an antipsychotic therapy drug for Parkinson’s disease. The Food and Drug Administration (FDA) continues to monitor the…

Read More